Background and aim: The objective of this cross-sectional study was to evaluate the degree of glycaemic control and the frequency of diabetic complications in Italian people with diabetes who were treated with continuous subcutaneous insulin infusion (CSII). Methods and results: Questionnaires investigating the organisation of diabetes care centres, individuals’ clinical and metabolic features and pump technology and its management were sent to adult and paediatric diabetes centres that use CSII for treatment in Italy. Information on standard clinical variables, demographic data and acute and chronic diabetic complications was derived from local clinical management systems. The sample consisted of 6623 people with diabetes, which was obtained from 93 centres. Of them, 98.8% had type 1 diabetes mellitus, 57.2% were female, 64% used a conventional insulin pump and 36% used a sensor-augmented insulin pump. The median glycated haemoglobin (HbA1c) level was 60 mmol/mol (7.6%). The HbA1c target (i.e. <58 mmol/mol for age <18 years and [removed]18 years) was achieved in 43.4% of paediatric and 23% of adult participants. Factors such as advanced pump functions, higher rate of sensor use, pregnancy in the year before the study and longer duration of diabetes were associated with lower HbA1c levels. The most common chronic complications occurring in diabetes were retinopathy, microalbuminuria and hypertension. In the year before the study, 5% of participants reported ≥1 episode of severe hypoglycaemic (SH) episodes (SH) and 2.6% reported ≥1 episode of ketoacidosis. Conclusions: Advanced personal skills and use of sensor-based pump are associated with better metabolic control outcomes in Italian people with diabetes who were treated with CSII. The reduction in SH episodes confirms the positive effect of CSII on hypoglycaemia. Clinical trial registration number: NCT 02620917 (ClinicalTrials.gov).

Lepore, G., Bonfanti, R., Bozzetto, L., Di Blasi, V., Girelli, A., Grassi, G., et al. (2018). Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 28(4), 335-342 [10.1016/j.numecd.2017.12.001].

Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion

Trevisan R.
Membro del Collaboration Group
;
Molinari C.
Membro del Collaboration Group
;
Perseghin G.
Membro del Collaboration Group
;
2018

Abstract

Background and aim: The objective of this cross-sectional study was to evaluate the degree of glycaemic control and the frequency of diabetic complications in Italian people with diabetes who were treated with continuous subcutaneous insulin infusion (CSII). Methods and results: Questionnaires investigating the organisation of diabetes care centres, individuals’ clinical and metabolic features and pump technology and its management were sent to adult and paediatric diabetes centres that use CSII for treatment in Italy. Information on standard clinical variables, demographic data and acute and chronic diabetic complications was derived from local clinical management systems. The sample consisted of 6623 people with diabetes, which was obtained from 93 centres. Of them, 98.8% had type 1 diabetes mellitus, 57.2% were female, 64% used a conventional insulin pump and 36% used a sensor-augmented insulin pump. The median glycated haemoglobin (HbA1c) level was 60 mmol/mol (7.6%). The HbA1c target (i.e. <58 mmol/mol for age <18 years and [removed]18 years) was achieved in 43.4% of paediatric and 23% of adult participants. Factors such as advanced pump functions, higher rate of sensor use, pregnancy in the year before the study and longer duration of diabetes were associated with lower HbA1c levels. The most common chronic complications occurring in diabetes were retinopathy, microalbuminuria and hypertension. In the year before the study, 5% of participants reported ≥1 episode of severe hypoglycaemic (SH) episodes (SH) and 2.6% reported ≥1 episode of ketoacidosis. Conclusions: Advanced personal skills and use of sensor-based pump are associated with better metabolic control outcomes in Italian people with diabetes who were treated with CSII. The reduction in SH episodes confirms the positive effect of CSII on hypoglycaemia. Clinical trial registration number: NCT 02620917 (ClinicalTrials.gov).
Articolo in rivista - Articolo scientifico
Acute and chronic complications; Continuous subcutaneous insulin infusion (CSII); Diabetes mellitus; Metabolic control;
English
335
342
8
Trevisan Roberto, Molinari Chiara e Perseghin Gianluca Italian Study Group on the Diffusion of CSII
Lepore, G., Bonfanti, R., Bozzetto, L., Di Blasi, V., Girelli, A., Grassi, G., et al. (2018). Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 28(4), 335-342 [10.1016/j.numecd.2017.12.001].
Lepore, G; Bonfanti, R; Bozzetto, L; Di Blasi, V; Girelli, A; Grassi, G; Iafusco, D; Laviola, L; Rabbone, I; Schiaffini, R; Bruttomesso, D; Mammi, F; Bruzzese, M; Schettino, M; Nuzzo, M; Di Blasi, V; Fresa, R; Lambiase, C; Zanfardino, A; Confetto, S; Bozzetto, L; Annuzzi, G; Alderisio, A; Riccardi, G; Gentile, S; Marino, G; Guarino, G; Zucchini, S; Maltoni, G; Suprani, T; Graziani, V; Nizzoli, M; Acquati, S; Cavani, R; Romano, S; Michelini, M; Manicardi, E; Bonadonna, R; Dei Cas, A; Dall'Aglio, E; Papi, M; Riboni, S; Manicardi, V; Pugni, V; Lasagni, A; Street, M; Pagliani, U; Rossi, C; Assaloni, R; Brunato, B; Tortul, C; Zanette, G; Li Volsi, P; Zanatta, M; Tonutti, L; Agus, S; Pellegrini, M; Ceccano, P; Pozzilli, G; Anguissola, B; Buzzetti, R; Moretti C, C; Leto, G; Pozzilli, P; Manfrini, S; Maurizi, A; Leotta, S; Altomare, M; Abbruzzese, S; Carletti, S; Suraci, C; Filetti, S; Manca Bitti, M; Arcano, S; Cavallo, M; De Bernardinis, M; Pitocco, D; Caputo, S; Rizzi, A; Manto, A; Schiaffini, R; Cappa, M; Benevento, D; Frontoni, S; Malandrucco, I; Morano, S; Filardi, T; Lauro, D; Marini, M; Castaldo, E; Sabato, D; Tuccinardi, F; Forte, E; Viterbori, P; Arnaldi, C; Minuto, N; D'Annunzio, G; Corsi, A; Rota, R; Scaranna, C; Trevisan, R; Valentini, U; Girelli, A; Bonfadini, S; Zarra, E; Plebani, A; Prandi, E; Felappi, B; Rocca, A; Meneghini, E; Galli, P; Ruggeri, P; Carrai, E; Fugazza, L; Baggi, V; Conti, D; Bosi, E; Laurenzi, A; Caretto, A; Molinari, C; Orsi, E; Grancini, V; Resi, V; Favalli, V; Bonura, C; Rigamonti, A; Bonomo, M; Bertuzzi, F; Pintaudi, B; Disoteo, O; Perseghin, G; Perra, S; Chiovato, L; De Cata, P; Zerbini, F; Lovati, E; Laneri, M; Guerraggio, L; Bossi, A; De Mori, V; Galetta, M; Meloncelli, I; Aiello A, A; Di Vincenzo, S; Nuzzi, A; Fraticelli, E; Ansaldi, E; Battezzati, M; Lombardi, M; Balbo, M; Lera, R; Secco, A; De Donno, V; Cadario, F; Savastio, S; Ponzani, C; Aimaretti, G; Rabbone, I; Ignaccolo, G; Tinti, D; Cerutti, F; Bari, F; Giorgino, F; Piccinno, E; Zecchino, O; Cignarelli, M; Lamacchia, O; Picca, G; De Cosmo, S; Rauseo, A; Tomaselli, L; Tumminia, A; Egiziano, C; Scarpitta, A; Maggio, F; Cardella, F; Roppolo, R; Provenzano, V; Fleres, M; Scorsone, A; Scatena, A; Gregori, G; Lucchesi, S; Gadducci, F; Di Cianni, S; Pancani, S; Del Prato, S; Aragona, M; Crisci, I; Calianno, A; Fattor, B; Crazzolara, D; Reinstadler, P; Longhi, S; Incelli, G; Rauch, S; Romanelli, T; Orrasch, M; Cauvin, V; Franceschi, R; Lalli, C; Pianta, A; Marangoni, A; Arico, C; Marin, N; Nogara, N; Simioni, N; Filippi, A; Gidoni Guarneri, G; Contin, M; Decata, A; Bondesan, L; Confortin, L; Coracina, A; Lombardi, S; Costa Padova, S; Cipponeri, E; Scotton, R; Galasso, S; Boscari, F; Zanon, M; Vinci, C; Lisato, G; Gottardo, L; Bonora, E; Trombetta, M; Negri, C; Brangani, C; Maffeis, C; Sabbion, A; Marigliano, M
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/382286
Citazioni
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
Social impact